Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 25726 | 2017 |
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck JA Bonner, PM Harari, J Giralt, N Azarnia, DM Shin, RB Cohen, CU Jones, ... New England Journal of Medicine 354 (6), 567-578, 2006 | 6503 | 2006 |
Nanoparticle Therapeutics: An Emerging New Treatment Modality for Cancer ME Davis, Z Chen, DM Shin Nature Reviews Drug Discovery 7, 771-782, 2008 | 5162 | 2008 |
Therapeutic nanoparticles for drug delivery in cancer K Cho, XU Wang, S Nie, Z Chen, DM Shin Clinical cancer research 14 (5), 1310-1316, 2008 | 3758 | 2008 |
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags X Qian, XH Peng, DO Ansari, Q Yin-Goen, GZ Chen, DM Shin, L Yang, ... Nature biotechnology 26 (1), 83-90, 2008 | 2757 | 2008 |
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer MR Posner, DM Hershock, CR Blajman, E Mickiewicz, E Winquist, ... New England Journal of Medicine 357 (17), 1705-1715, 2007 | 2089 | 2007 |
Recent advances in head and neck cancer RI Haddad, DM Shin New England Journal of Medicine 359 (11), 1143-1154, 2008 | 1142 | 2008 |
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery R Sinha, GJ Kim, S Nie, DM Shin Molecular cancer therapeutics 5 (8), 1909-1917, 2006 | 1082 | 2006 |
Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer. JA Roth, D Nguyen, DD Lawrence, BL Kemp, CH Carrasco, DZ Ferson, ... Nature medicine 2 (9), 985-991, 1996 | 1012 | 1996 |
Induction of p53 regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (RPR/INGN 201) and radiation therapy SG Swisher, JA Roth, R Komaki, J Gu, JJ Lee, M Hicks, J Ro, WK Hong, ... Clin Cancer Res 9, 93-101, 2002 | 909* | 2002 |
Application of nanotechnology in cancer therapy and imaging X Wang, L Yang, Z Chen, DM Shin CA: a cancer journal for clinicians 58 (2), 97-110, 2008 | 895 | 2008 |
Perspectives for cancer prevention with natural compounds ARMR Amin, O Kucuk, FR Khuri, DM Shin Journal of clinical oncology 27 (16), 2712-2725, 2009 | 753 | 2009 |
Monoclonal antibodies to target epidermal growth factor receptor–positive tumors: a new paradigm for cancer therapy RS Herbst, DM Shin Cancer 94 (5), 1593-1611, 2002 | 714 | 2002 |
Targeted Magnetic Iron Oxide Nanoparticles for Tumor Imaging and Therapy XH Peng, X Qian, H Mao, AY Wang, C Z(G), SM Nie, DM Shin Int J Nanomedicine 3 3, 311-321, 2008 | 628 | 2008 |
Predicting cancer development in oral leukoplakia: ten years of translational research JJ Lee, WK Hong, WN Hittelman, L Mao, R Lotan, DM Shin, SE Benner, ... Clinical Cancer Research 6 (5), 1702-1710, 2000 | 613 | 2000 |
Cancer prevention with natural compounds NP Gullett, ARMR Amin, S Bayraktar, JM Pezzuto, DM Shin, FR Khuri, ... Seminars in oncology 37 (3), 258-281, 2010 | 600 | 2010 |
Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer WK Murphy, FV Fossella, RJ Winn, DM Shin, HE Hynes, HM Gross, ... JNCI: Journal of the National Cancer Institute 85 (5), 384-388, 1993 | 585 | 1993 |
Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck RS Herbst, M Arquette, DM Shin, K Dicke, EE Vokes, N Azarnia, WK Hong, ... Journal of Clinical Oncology 23 (24), 5578-5587, 2005 | 517 | 2005 |
A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands X Huang, X Peng, Y Wang, Y Wang, DM Shin, MA El-Sayed, S Nie ACS nano 4 (10), 5887-5896, 2010 | 512 | 2010 |
Adenovirus-Mediated p53 Gene Transfer in Sequence With Cisplatin to Tumors of Patients With Non–Small-Cell Lung Cancer J Nemunaitis, SG Swisher, T Timmons, D Connors, M Mack, L Doerksen, ... Journal of clinical oncology 18 (3), 609-609, 2000 | 446 | 2000 |